Daybreak

Last year in October, the Karnataka government banned Ola and Uber autorickshaws after they were caught overcharging. A month later a new app was launched and it was almost antithesis of Ola and Uber. It charged zero commission from drivers and no cancellation or surge charges from riders. Plus, the government supported it by saying it would be listed on its e-commerce behemoth, ONDC.Yet, eight months later, Namma Yatri is not growing as much as expected in terms of registered drivers and users. Tune in to find out more.Recommended reading: Your Namma Yatri auto driver may still be on Uber, OlaAlso, listen to: Gaurav Munjal of Unacademy on being confrontational, paranoid and transparentDaybreak is produced from the newsroom of The Ken, India's first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, analytical business stories.  

Freshworks, one of the most successful SaaS companies that was listed on Nasdaq in 2021, wanted to hit $1 billion in annualised revenue by 2023. What made it stand out was also its employee-first approach.That it took the company just 5 years to climb from $1 million in ARR in 2010 hit $100 million indicated that the target could've been achieved. but it's 2023, and Freshworks is only halfway towards the goal.How is the company planning to pursue its profit goals?Tune in to fine out.Recommended reading: How Freshworks is going from being a ‘people-first’ to a ‘profits-first’ companySubscribe to The Ken for more exclusive, deeply-reported, analytical business stories.

The pandemic worsened the nursing crisis in India. If 35 nurses were required for every 10,000 people, India only has 25. Exploitative work conditions and poor pay are making nurses migrate in huge numbers to other countries for better jobs. It is an exodus.The government on its part its trying to solve the crisis by building more nursing colleges. But this is akin to a doctor treating the symptom instead of the disease.Tune in to find out why.

India’s nutraceutical market is estimated  to be worth $4-5 billion and the government expects it to be worth almost five times more in the next two years. As important as it is to monitor the rapidly growing market, regulations have not really kept up.And in a post-Covid world where preventive healthcare has become all the rage, a dangerous situation is being created. Health supplement makers are flouting RDA guidelines and consumers have been paying little attention.Tune in to find out why you need to read the fine print before you buy your next dose of multivitamin gummies.Recommended reading: How healthy are health supplements? India’s food regulator wants to find outDaybreak is produced from the newsroom of The Ken, India's first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, analytical business stories.  

Last week, a full search and seizure operation was carried out by the Enforcement Directorate on three offices of edtech giant Byju's. The $22 billion startup is being investigated under the Foreign Exchange Management Act.The move comes at a terrible time for Byju's since it is already struggling with a long list of troubles including a potential debt crisis. The company still hasn't filed its financials for FY 2022.In this episode, not only do we look back at Byju’s missteps, we also go over what it did right, and how it still did not matter.Tune in.Recommended reading: The seven things you need to know about Byju’s FY21 financialsSubscribe to The Ken for more exclusive, deeply-reported, analytical business stories.

The launch of Chinese video content platform Tiktok in 2017 changed the social media landscape forever. The short video format became all the rage. Despite TikTok being banned in 2020, the format stayed and a range of Indian short-video apps came up.Content creators from small towns and cities joined such platforms and for many it became a dependable source of income. Some were making as much as Rs 1 lakh a month.But now, with advertisers slashing their budgets, platforms such as Moj and Josh are ending their exclusive deals with content-creators.What seemed like a viable career option for thousands across the country is no longer the same.Tune in.

The initial public offering ((IPO) of Mankind Pharma Ltd opened for subscription on 25th April and closed just yesterday. The pharma major is reportedly eyeing a valuation of over $6.7 billion.But in recent years, the Indian stock market has not been very kind to pharmas that have been listed. Since 2010, 17 of them have had IPOs, but four have delisted. Of the remaining, half are trading below their listing price.Amidst this and the current economic state that is making many postpone their IPOs, Mankind still went ahead with its plan. Why?Tune in to find out. 

In February this year, Vodafone Idea gave away a 33% stake to the Indian government and the government converted a part of its dues into equity. Many analysts though think even this cannot save the sinking telco.Because the company still owes the government $23 billion and banks $1.5 billion. And it also needs $6 billion for an all-India network upgrade to roll out 5G.Vodafone Idea has too much to deal with—a towering mountain of debt, a ruthless giant of a rival, and the merger with Idea that turned out to be a bad decision.  In today's episode, we look at the possible outcomes of how the saga of the struggling telco could end.Tune in.

Ever since they came up a little less than a decade ago, e-pharmacies have been fighting a constant battle. On one hand there is the severe pushback from traditional pharmacy lobbies and on the other, the lack of a regulatory mechanism.It was only in 2017 that the government officially acknowledged their existence. It was a small win, but a win nonetheless. But the draft e-pharmacy rules that the government came up with a year later were never notified.Despite this, e-pharmacies continued operating and their importance was only highlighted further during the pandemic.But in February this year, the Central Drugs Standard Control Organisation (CDSCO) sent show-cause notices to 20 e-pharmacies. These included Tata 1mg, Amazon, Flipkart, Reliance Retail-owned NetMeds, MediBuddy, Practo and Apollo.However, e-pharmacies are here to stay.Tune in to find out more

In 2020, Google invested $4.5 billion  in Reliance's Jio Platforms for a 7.7% equity. The flagship product of this alliance was a budget friendly 4G smartphone priced at Rs 6500 called JioPhone Next. The idea was to make the internet more accessible to millions of more Indians.When it was launched, the telco was expected to sell at least 20 million devices in a year. But so far, it has sold only 2 million.A tech giant and a telco giant coming together to make a pocket-friendly smartphone--the plan sounded perfect. What could've gone wrong?Tune in to find out.